Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

GILD US

Home Stock Screener Document Search Charting Watchlists Recent Filings

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

GILD US

Home Stock Screener Document Search Charting Watchlists Recent Filings

Gilead Sciences, Inc.(GILD US)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Gilead Sciences, Inc.(GILD US)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Financials & Metrics

Financials Charting Short Interest Employees

Financials & Metrics

Financials Charting Short Interest Employees

SEC Filings

SEC Filings

Financials(124)

10-QQ3ended 30 Sept 202629 Oct
10-QQ2ended 30 Jun 20266 Aug
10-QQ1ended 31 Mar 20267 May
10-KFY 2025ended 31 Dec 202524 Feb
10-QQ3ended 30 Sept 20257 Nov 2025
10-QQ2ended 30 Jun 20257 Aug 2025
10-QQ1ended 31 Mar 20257 May 2025
10-KFY 2024ended 31 Dec 202428 Feb 2025
10-QQ3ended 30 Sept 202412 Nov 2024
10-QQ2ended 30 Jun 20248 Aug 2024
10-QQ1ended 31 Mar 20248 May 2024
10-KFY 2023ended 31 Dec 202323 Feb 2024
10-QQ3ended 30 Sept 20237 Nov 2023
10-QQ2ended 30 Jun 20234 Aug 2023
10-QQ1ended 31 Mar 20233 May 2023

Events(318)

8-KResults of Operations and Financial Condition29 Oct
8-KResults of Operations and Financial Condition4 Aug
8-KEntry into a Material Definitive Agreement20 May
8-KResults of Operations and Financial Condition7 May
8-KSubmission of Matters to a Vote of Security Holders4 May
8-KRegulation FD Disclosure28 Apr
8-KEntry into a Material Definitive Agreement23 Feb
8-KResults of Operations and Financial Condition10 Feb
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers19 Nov 2025
8-KResults of Operations and Financial Condition30 Oct 2025
8-KRegulation FD Disclosure6 Oct 2025
8-KDirector/Officer Changes & Compensatory Arrangements14 Aug 2025
8-KResults of Operations and Financial Condition7 Aug 2025
8-KCharter/Bylaw Amendment; Fiscal Year Change4 Aug 2025
8-KSubmission of Matters to Shareholder Vote8 May 2025

Insider Ownership(2K)

Form 4Cain Wettan Keeley M9 Nov
Form 4O'Day Daniel Patrick6 Nov
Form 4O'Day Daniel Patrick2 Nov
Form 4Dickinson Andrew D16 Oct
Form 4Mercier Johanna16 Oct
Form 4O'Day Daniel Patrick2 Oct
Form 4Burkhart Erin23 Sep
Form 4Dickinson Andrew D16 Sep
Form 4Mercier Johanna16 Sep
Form 4Dickinson Andrew D11 Sep
Form 4Berger Dietmar11 Sep
Form 4Mercier Johanna11 Sep
Form 4Cain Wettan Keeley M11 Sep
Form 4O'Day Daniel Patrick11 Sep
Form 4O'Day Daniel Patrick2 Sep

Beneficial Ownership(179)

SC 13GAspen Neuroscience, Inc.6 Nov
SC 13D/AArcus Biosciences, Inc.7 Aug
SC 13D/AASSEMBLY BIOSCIENCES, INC.27 May
SC 13GGILEAD SCIENCES, INC.29 Apr
SC 13D/AArcellx, Inc.28 Apr
SC 13G/AGILEAD SCIENCES, INC.26 Mar
SC 13DArcellx, Inc.23 Feb
SC 13G/AXilio Therapeutics, Inc.12 Feb
SC 13G/ACYPHERPUNK TECHNOLOGIES INC.12 Feb
SC 13GGILEAD SCIENCES, INC.5 Feb
SC 13D/AArcus Biosciences, Inc.5 Nov 2025
SC 13G/AXilio Therapeutics, Inc.14 Aug 2025
SC 13D/AASSEMBLY BIOSCIENCES, INC.12 Aug 2025
SC 13D/AArcus Biosciences, Inc.15 Jul 2025
SC 13G/AGILEAD SCIENCES, INC.13 May 2025

Other Ownership(101)

Form 144Kramer Kelly A.12 Nov
Form 144Cain Wettan Keeley M6 Nov
13F-HRQuarterly report (institutional investment manager holdings)5 Nov
Form 144O'Day Daniel Patrick4 Nov
Form 144O'Day Daniel Patrick30 Oct
Form 144Mercier Johanna15 Oct
Form 144Dickinson Andrew D15 Oct
Form 144Mercier Johanna15 Sep
Form 144Dickinson Andrew D15 Sep
Form 144WELTERS ANTHONY26 Aug
Form 144Bluestone Jeffrey20 Aug
Form 144Mercier Johanna17 Aug
Form 144Dickinson Andrew D17 Aug
Form 144O'Day Daniel Patrick3 Aug
13F-HRQuarterly report (institutional investment manager holdings)3 Aug

Proxies(84)

N-PXAnnual report of proxy voting record26 Aug
ARSANNUAL REPORT TO SECURITY HOLDERS20 Mar
DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS20 Mar
DEF 14ADEFINITIVE PROXY STATEMENT20 Mar
N-PXAnnual report of proxy voting record29 Aug 2025
PX14A6GNotice of exempt solicitation7 Apr 2025
DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS27 Mar 2025
DEF 14ADEFINITIVE PROXY STATEMENT27 Mar 2025
ARSANNUAL REPORT TO SECURITY HOLDERS27 Mar 2025
ARSAnnual report to security holders28 Mar 2024
DEF 14ADefinitive proxy statement28 Mar 2024
DEFA14ADefinitive additional materials28 Mar 2024
PRE 14APreliminary proxy statement18 Mar 2024
PX14A6GNotice of exempt solicitation6 Apr 2023
DEFR14ADefinitive revised proxy statement5 Apr 2023

Registrations(115)

S-3ASRAutomatic shelf registration statement (S-3)6 Aug
424B5Prospectus filing (Rule 424(b)(5))18 May
FWPFree writing prospectus14 May
424B5Prospectus filing (Rule 424(b)(5))14 May
S-8Registration statement (employee benefit plan)7 May
424B5Prospectus filing (Rule 424(b)(5))15 Nov 2024
424B5Prospectus filing (Rule 424(b)(5))13 Nov 2024
FWPFree writing prospectus13 Nov 2024
424B5Prospectus filing (Rule 424(b)(5))11 Sep 2023
424B5Prospectus filing (Rule 424(b)(5))7 Sep 2023
FWPFree writing prospectus7 Sep 2023
S-8Registration statement (employee benefit plan)7 Aug 2023
S-3ASRAutomatic shelf registration statement (S-3)4 Aug 2023
S-8Registration statement (employee benefit plan)5 May 2022
S-8Registration statement (employee benefit plan)4 Nov 2020

Filing Review Correspondence(10)

CORRESPFiling review correspondence11 Mar 2024
CORRESPFiling review correspondence25 Apr 2023
CORRESPFiling review correspondence2 Oct 2020
CORRESPFiling review correspondence18 Sep 2017
UPLOADFiling review upload13 May 2008
CORRESPFiling review correspondence29 Apr 2008
UPLOADFiling review upload1 Apr 2008
CORRESPFiling review correspondence31 Aug 2006
CORRESPFiling review correspondence9 Aug 2006
UPLOADFiling review upload4 Aug 2006

SEC Orders And Notices(87)

CT ORDERConfidential treatment order2 Feb 2022
CT ORDERConfidential treatment order14 Apr 2020
CT ORDERConfidential treatment order14 Apr 2020
CT ORDERConfidential treatment order14 Apr 2020
CT ORDERConfidential treatment order28 Jan 2020
CT ORDERConfidential treatment order12 Jul 2019
CT ORDERConfidential treatment order12 Jul 2019
CT ORDERConfidential treatment order7 Jun 2019
CT ORDERConfidential treatment order21 Feb 2019
CT ORDERConfidential treatment order13 Nov 2018
CT ORDERConfidential treatment order27 Sep 2018
CT ORDERConfidential treatment order14 Sep 2018
CT ORDERConfidential treatment order16 Aug 2018
CT ORDERConfidential treatment order18 May 2018
CT ORDERConfidential treatment order26 Jan 2018

Tender Offers And Going Private(77)

SC TO-T/ATender offer statement (third-party, amendment)28 Apr
SC TO-T/ATender offer statement (third-party, amendment)17 Apr
SC TO-T/ATender offer statement (third-party, amendment)1 Apr
SC TO-TTender offer statement (third-party)6 Mar
SC TO-CTender offer statement (communication)23 Feb
SC TO-CTender offer statement (communication)23 Feb
SC TO-T/ATender offer statement (third-party, amendment)22 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)20 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)15 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)11 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)28 Feb 2024
SC TO-TTender offer statement (third-party)23 Feb 2024
SC TO-CTender offer statement (communication)14 Feb 2024
SC TO-CTender offer statement (communication)12 Feb 2024
SC TO-CTender offer statement (communication)12 Feb 2024

Other(14)

NO ACTAUTO-GENERATED PAPER DOCUMENT10 Feb 2017
NO ACTAUTO-GENERATED PAPER DOCUMENT26 Feb 2015
NO ACTAUTO-GENERATED PAPER DOCUMENT23 Feb 2015
NO ACTAUTO-GENERATED PAPER DOCUMENT21 Feb 2014
IRANNOTICEGILEAD IRAN NOTICE27 Feb 2013
NO ACTAUTO-GENERATED PAPER DOCUMENT4 Jan 2011
NO ACTAUTO-GENERATED PAPER DOCUMENT19 Feb 2010
DEFS14ADEFS14A20 Dec 2000
PRES14APRES14A8 Dec 2000
10-K40510-K40530 Mar 2000
10-K405/A10-K405/A23 Jun 1999
10-K40510-K40522 Mar 1999
10-K40510-K40531 Mar 1998
10-K40510-K40521 Mar 1997

Financials(124)

10-QQ3ended 30 Sept 202629 Oct
10-QQ2ended 30 Jun 20266 Aug
10-QQ1ended 31 Mar 20267 May
10-KFY 2025ended 31 Dec 202524 Feb
10-QQ3ended 30 Sept 20257 Nov 2025
10-QQ2ended 30 Jun 20257 Aug 2025
10-QQ1ended 31 Mar 20257 May 2025
10-KFY 2024ended 31 Dec 202428 Feb 2025
10-QQ3ended 30 Sept 202412 Nov 2024
10-QQ2ended 30 Jun 20248 Aug 2024
10-QQ1ended 31 Mar 20248 May 2024
10-KFY 2023ended 31 Dec 202323 Feb 2024
10-QQ3ended 30 Sept 20237 Nov 2023
10-QQ2ended 30 Jun 20234 Aug 2023
10-QQ1ended 31 Mar 20233 May 2023

Events(318)

8-KResults of Operations and Financial Condition29 Oct
8-KResults of Operations and Financial Condition4 Aug
8-KEntry into a Material Definitive Agreement20 May
8-KResults of Operations and Financial Condition7 May
8-KSubmission of Matters to a Vote of Security Holders4 May
8-KRegulation FD Disclosure28 Apr
8-KEntry into a Material Definitive Agreement23 Feb
8-KResults of Operations and Financial Condition10 Feb
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers19 Nov 2025
8-KResults of Operations and Financial Condition30 Oct 2025
8-KRegulation FD Disclosure6 Oct 2025
8-KDirector/Officer Changes & Compensatory Arrangements14 Aug 2025
8-KResults of Operations and Financial Condition7 Aug 2025
8-KCharter/Bylaw Amendment; Fiscal Year Change4 Aug 2025
8-KSubmission of Matters to Shareholder Vote8 May 2025

Insider Ownership(2K)

Form 4Cain Wettan Keeley M9 Nov
Form 4O'Day Daniel Patrick6 Nov
Form 4O'Day Daniel Patrick2 Nov
Form 4Dickinson Andrew D16 Oct
Form 4Mercier Johanna16 Oct
Form 4O'Day Daniel Patrick2 Oct
Form 4Burkhart Erin23 Sep
Form 4Dickinson Andrew D16 Sep
Form 4Mercier Johanna16 Sep
Form 4Dickinson Andrew D11 Sep
Form 4Berger Dietmar11 Sep
Form 4Mercier Johanna11 Sep
Form 4Cain Wettan Keeley M11 Sep
Form 4O'Day Daniel Patrick11 Sep
Form 4O'Day Daniel Patrick2 Sep

Beneficial Ownership(179)

SC 13GAspen Neuroscience, Inc.6 Nov
SC 13D/AArcus Biosciences, Inc.7 Aug
SC 13D/AASSEMBLY BIOSCIENCES, INC.27 May
SC 13GGILEAD SCIENCES, INC.29 Apr
SC 13D/AArcellx, Inc.28 Apr
SC 13G/AGILEAD SCIENCES, INC.26 Mar
SC 13DArcellx, Inc.23 Feb
SC 13G/AXilio Therapeutics, Inc.12 Feb
SC 13G/ACYPHERPUNK TECHNOLOGIES INC.12 Feb
SC 13GGILEAD SCIENCES, INC.5 Feb
SC 13D/AArcus Biosciences, Inc.5 Nov 2025
SC 13G/AXilio Therapeutics, Inc.14 Aug 2025
SC 13D/AASSEMBLY BIOSCIENCES, INC.12 Aug 2025
SC 13D/AArcus Biosciences, Inc.15 Jul 2025
SC 13G/AGILEAD SCIENCES, INC.13 May 2025

Other Ownership(101)

Form 144Kramer Kelly A.12 Nov
Form 144Cain Wettan Keeley M6 Nov
13F-HRQuarterly report (institutional investment manager holdings)5 Nov
Form 144O'Day Daniel Patrick4 Nov
Form 144O'Day Daniel Patrick30 Oct
Form 144Mercier Johanna15 Oct
Form 144Dickinson Andrew D15 Oct
Form 144Mercier Johanna15 Sep
Form 144Dickinson Andrew D15 Sep
Form 144WELTERS ANTHONY26 Aug
Form 144Bluestone Jeffrey20 Aug
Form 144Mercier Johanna17 Aug
Form 144Dickinson Andrew D17 Aug
Form 144O'Day Daniel Patrick3 Aug
13F-HRQuarterly report (institutional investment manager holdings)3 Aug

Proxies(84)

N-PXAnnual report of proxy voting record26 Aug
ARSANNUAL REPORT TO SECURITY HOLDERS20 Mar
DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS20 Mar
DEF 14ADEFINITIVE PROXY STATEMENT20 Mar
N-PXAnnual report of proxy voting record29 Aug 2025
PX14A6GNotice of exempt solicitation7 Apr 2025
DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS27 Mar 2025
DEF 14ADEFINITIVE PROXY STATEMENT27 Mar 2025
ARSANNUAL REPORT TO SECURITY HOLDERS27 Mar 2025
ARSAnnual report to security holders28 Mar 2024
DEF 14ADefinitive proxy statement28 Mar 2024
DEFA14ADefinitive additional materials28 Mar 2024
PRE 14APreliminary proxy statement18 Mar 2024
PX14A6GNotice of exempt solicitation6 Apr 2023
DEFR14ADefinitive revised proxy statement5 Apr 2023

Registrations(115)

S-3ASRAutomatic shelf registration statement (S-3)6 Aug
424B5Prospectus filing (Rule 424(b)(5))18 May
FWPFree writing prospectus14 May
424B5Prospectus filing (Rule 424(b)(5))14 May
S-8Registration statement (employee benefit plan)7 May
424B5Prospectus filing (Rule 424(b)(5))15 Nov 2024
424B5Prospectus filing (Rule 424(b)(5))13 Nov 2024
FWPFree writing prospectus13 Nov 2024
424B5Prospectus filing (Rule 424(b)(5))11 Sep 2023
424B5Prospectus filing (Rule 424(b)(5))7 Sep 2023
FWPFree writing prospectus7 Sep 2023
S-8Registration statement (employee benefit plan)7 Aug 2023
S-3ASRAutomatic shelf registration statement (S-3)4 Aug 2023
S-8Registration statement (employee benefit plan)5 May 2022
S-8Registration statement (employee benefit plan)4 Nov 2020

Filing Review Correspondence(10)

CORRESPFiling review correspondence11 Mar 2024
CORRESPFiling review correspondence25 Apr 2023
CORRESPFiling review correspondence2 Oct 2020
CORRESPFiling review correspondence18 Sep 2017
UPLOADFiling review upload13 May 2008
CORRESPFiling review correspondence29 Apr 2008
UPLOADFiling review upload1 Apr 2008
CORRESPFiling review correspondence31 Aug 2006
CORRESPFiling review correspondence9 Aug 2006
UPLOADFiling review upload4 Aug 2006

SEC Orders And Notices(87)

CT ORDERConfidential treatment order2 Feb 2022
CT ORDERConfidential treatment order14 Apr 2020
CT ORDERConfidential treatment order14 Apr 2020
CT ORDERConfidential treatment order14 Apr 2020
CT ORDERConfidential treatment order28 Jan 2020
CT ORDERConfidential treatment order12 Jul 2019
CT ORDERConfidential treatment order12 Jul 2019
CT ORDERConfidential treatment order7 Jun 2019
CT ORDERConfidential treatment order21 Feb 2019
CT ORDERConfidential treatment order13 Nov 2018
CT ORDERConfidential treatment order27 Sep 2018
CT ORDERConfidential treatment order14 Sep 2018
CT ORDERConfidential treatment order16 Aug 2018
CT ORDERConfidential treatment order18 May 2018
CT ORDERConfidential treatment order26 Jan 2018

Tender Offers And Going Private(77)

SC TO-T/ATender offer statement (third-party, amendment)28 Apr
SC TO-T/ATender offer statement (third-party, amendment)17 Apr
SC TO-T/ATender offer statement (third-party, amendment)1 Apr
SC TO-TTender offer statement (third-party)6 Mar
SC TO-CTender offer statement (communication)23 Feb
SC TO-CTender offer statement (communication)23 Feb
SC TO-T/ATender offer statement (third-party, amendment)22 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)20 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)15 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)11 Mar 2024
SC TO-T/ATender offer statement (third-party, amendment)28 Feb 2024
SC TO-TTender offer statement (third-party)23 Feb 2024
SC TO-CTender offer statement (communication)14 Feb 2024
SC TO-CTender offer statement (communication)12 Feb 2024
SC TO-CTender offer statement (communication)12 Feb 2024

Other(14)

NO ACTAUTO-GENERATED PAPER DOCUMENT10 Feb 2017
NO ACTAUTO-GENERATED PAPER DOCUMENT26 Feb 2015
NO ACTAUTO-GENERATED PAPER DOCUMENT23 Feb 2015
NO ACTAUTO-GENERATED PAPER DOCUMENT21 Feb 2014
IRANNOTICEGILEAD IRAN NOTICE27 Feb 2013
NO ACTAUTO-GENERATED PAPER DOCUMENT4 Jan 2011
NO ACTAUTO-GENERATED PAPER DOCUMENT19 Feb 2010
DEFS14ADEFS14A20 Dec 2000
PRES14APRES14A8 Dec 2000
10-K40510-K40530 Mar 2000
10-K405/A10-K405/A23 Jun 1999
10-K40510-K40522 Mar 1999
10-K40510-K40531 Mar 1998
10-K40510-K40521 Mar 1997